<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Sporanox preparations; Itraconazole" /><meta name="IX" content="Sporanox preparations; Itraconazole" /><title>Sporanox®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="265/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="35091.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="3982.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="3982.htm#pB" title="Skip Navigation">Skip Navigation</a><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=3982.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 26 May 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF No. 63 (March 2012)</a> &gt; <a href="2071.htm">5 Infections</a> &gt; <a href="3968.htm">5.2 Antifungal drugs</a> &gt; <a href="208201.htm">5.2.1 Triazole antifungals</a> &gt; <a href="3981.htm">ITRACONAZOLE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="3974.htm" title="Previous: FLUCONAZOLE">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="129707.htm" title="Next: POSACONAZOLE">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a392049.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antifungals 8:14 &gt; Azoles 8:14.08</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/18657-x.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Itraconazole</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: I &gt; Interactions of Itraconazole</p></div></li></ul><ul><li><h3>British National Formulary (5)</h3></li><li><a href="102291.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Treatment of fungal infections</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs</p></div></li><li><a href="208201.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.2.1 Triazole antifungals</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs</p></div></li><li><a href="3981.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ITRACONAZOLE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs &gt; 5.2.1 Triazole antifungals</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22itraconazole%22%22itraconazole%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (5)</a></li></ul><ul><li><h3>BNF for Children (6)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/102291.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Treatment of fungal infections</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/214569.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.2.1 Triazole antifungals</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/3981.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">ITRACONAZOLE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.2 Antifungal drugs &gt; 5.2.1 Triazole antifungals</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22itraconazole%22%22itraconazole%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (6)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK0911.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; I</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0009s0148.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Injectable Drugs Guide</h3></li><li><a href="http://www.medicinescomplete.com/mc/idg/2010/I12-mn0001.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>Injectable Drugs Guide</strong> &gt; Injectable Drugs Guide &gt; Monographs &gt; I</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/itraconazole_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Fungal Drugs &gt; Systemic Azoles &gt; 133 Itraconazole</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/itraconazole_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Fungal Drugs &gt; Systemic Azoles &gt; 133 Itraconazole</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/itraconazole_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Anti-Fungal Drugs &gt; Systemic Azoles &gt; 133 Itraconazole</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22itraconazole%22%22itraconazole%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/18657-x.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antifungals &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/05245.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; I &gt; IT</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E26E3E0R0D217.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Itraconazole</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; I</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c200.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Itraconazole</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; I</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1 id="_3981">ITRACONAZOLE</h1><div id="pC" class="jN"><div class="cAJ"><span class="cAD">Additional information</span> interactions (<a href="41001i302.htm" title="Go to appendix 1">Itraconazole</a>).</div><div class="cAF"><h2>Indications</h2> <p class="cAF">see under Dose</p></div><div class="cAF" id="_3981.1"><h2>Cautions</h2> <p class="cAF">absorption
reduced in HIV-infection and neutropenia (monitor plasma-<span>itraconazole</span> concentration and increase dose if necessary); susceptibility to congestive heart failure (see also
Heart Failure, below); <b>interactions:</b> Appendix 1 (antifungals,
triazole)</p><div class="cAV"><h3>Hepatotoxicity</h3> <p class="cAX">Potentially life-threatening hepatotoxicity
reported very rarely—discontinue if signs of hepatitis
develop. Avoid or use with caution if history
of hepatotoxicity with other drugs or in active liver disease. Monitor liver function
if treatment continues for longer than one month, if receiving other
hepatotoxic drugs, if history of hepatotoxicity with other drugs,
or in hepatic impairment</p></div><div id="_3981.2"><div class="cAV"><h3>Counselling</h3> <p class="cAX">Patients should be told
how to recognise signs of liver disorder and advised to seek prompt
medical attention if symptoms such as anorexia, nausea, vomiting,
fatigue, abdominal pain or dark urine develop</p></div></div><div class="cN"><h3 class="cBP">Heart failure</h3><p>Following reports of heart failure, caution is advised when
prescribing itraconazole to patients at high risk of
heart failure. Those at risk include:</p><ul class="cBF"><li><p class="cQ">patients receiving high doses and longer treatment courses;</p></li><li><p class="cQ">older patients and those with cardiac disease;</p></li><li><p class="cQ">patients receiving treatment with negative
inotropic drugs, e.g. calcium channel blockers.</p></li></ul><p>Itraconazole should be avoided in patients with ventricular
dysfunction or a history of heart failure unless the infection is
serious.</p></div></div><div class="cAF"><h2>Contra-indications</h2> <p class="cAF">acute porphyria (<a title="sub-section: Acute porphyrias" href="5181.htm#_5181">section 9.8.2</a>)</p></div><div class="cAF"><h2>Hepatic impairment</h2> <p class="cAF">use only if potential benefit outweighs risk of hepatotoxicity
(see Hepatotoxicity above); dose reduction may be necessary</p></div><div class="cAF"><h2>Renal impairment</h2> <p class="cAF">risk of congestive heart failure; bioavailability of
oral formulations possibly reduced; use intravenous infusion with
caution if eGFR 30–80 mL/minute/1.73 m<sup>2</sup>; avoid intravenous
infusion if eGFR less than 30 mL/minute/1.73m<sup>2</sup></p></div><div class="cAF"><h2>Pregnancy</h2> <p class="cAF">manufacturer advises use only in life-threatening
situations (toxicity at high doses in <i>animal</i> studies);
ensure effective contraception during treatment and until the next
menstrual period following end of treatment</p></div><div class="cAF"><h2>Breast-feeding</h2> <p class="cAF">small amounts present in milk—may accumulate;
manufacturer advises avoid</p></div><div class="cAF"><h2>Side-effects</h2> <p class="cAF">nausea, abdominal pain, rash; <i>less commonly</i> vomiting, dyspepsia, taste disturbances, flatulence, diarrhoea,
constipation, oedema, headache, dizziness, paraesthesia (discontinue
treatment if neuropathy), menstrual disorder, and alopecia; <i>rarely</i> pancreatitis, dyspnoea, hypoaesthesia, urinary frequency,
leucopenia, visual disturbances, and tinnitus; also reported, heart
failure (see Cautions above), hypertriglyceridaemia, hepatitis (see
Hepatotoxicity above), erectile dysfunction, thrombocytopenia,
hypokalaemia, myalgia, arthralgia, photosensitivity, toxic epidermal
necrolysis, and Stevens–Johnson syndrome; <i>with intravenous
injection</i> hypertension and hyperglycaemia</p></div><div class="cAF"><h2>Dose</h2> <p class="cR"><span class="cU">By mouth</span>, oropharyngeal candidiasis,
see under <span class="cZ">Sporanox</span>® oral liquid below</p><p class="cS">Vulvovaginal candidiasis, (see also Recurrent Vulvovaginal Candidiasis, <a title="BNF:target-block: recurrent vulvovaginal candidiasis" href="4533.htm#_4533.1">section 7.2.2</a>) 200 mg
twice daily for 1 day</p><p class="cS">Pityriasis versicolor, 200 mg once daily for 7 days</p><p class="cS">Tinea corporis and tinea cruris, <i>either</i> 100 mg
once daily for 15 days <i>or</i> 200 mg once daily for 7
days</p><p class="cS">Tinea pedis and tinea manuum, <i>either</i> 100 mg
once daily for 30 days <i>or</i> 200 mg twice daily for
7 days</p><p class="cS">Onychomycosis, <i>either</i> 200 mg once daily for
3 months <i>or</i> course (‘pulse’) of 200 mg twice daily
for 7 days, subsequent courses repeated after 21-day interval; fingernails
2 courses, toenails 3 courses</p><p class="cS">Aspergillosis, 200 mg twice daily</p><p class="cS">Histoplasmosis, 200 mg 3 times daily for 3 days, then 200 mg
once or twice daily</p><p class="cS">Systemic candidiasis and cryptococcosis including cryptococcal
meningitis where other antifungal drugs inappropriate or ineffective,
200 mg once daily (candidiasis 100–200 mg once daily) increased in
invasive or disseminated disease and in cryptococcal meningitis to
200 mg twice daily</p><p class="cS">Maintenance in HIV-infected patients to prevent relapse of underlying
fungal infection and prophylaxis in neutropenia when standard therapy
inappropriate, 200 mg once daily, increased to 200 mg twice daily
if low plasma-<span>itraconazole</span> concentration (see Cautions)</p><p class="cS">Prophylaxis in patients with haematological malignancy or undergoing
bone-marrow transplant, see under <span class="cZ">Sporanox</span>® oral
liquid below</p><p class="cR"><span class="cU">By intravenous infusion</span>, systemic
aspergillosis, candidiasis and cryptococcosis including cryptococcal
meningitis where other antifungal drugs inappropriate or ineffective,
histoplasmosis, 200 mg every 12 hours for 2 days, then 200 mg once
daily for max. 12 days</p><p class="cR"><span class="cAK">child</span> under 18 years
see <a href="http://www.medicinescomplete.com/mc/bnfc/current/3981.htm" title="BNFC:monograph: ITRACONAZOLE"><i>BNF for Children</i></a></p><div class="cAR"><h3>Note</h3> <p class="cAX">Itraconazole doses in BNF may differ from
those in product literature</p></div></div></div><?highlighter on?><div id="pS"><p>Sub-sections</p><ul class="jT"><li><a href="202624.htm#_202624" title="Itraconazole">Itraconazole</a></li><li class="jN" id="_3982" style="margin: 0 0 0 20px;"><h1 class="title">Sporanox®<span> (<a href="appendix-112803-J.htm#m401">Janssen</a>)</span> <img class="cJ" src="images/pom_l.png" title="Prescription-only Medicine" alt="Prescription-only Medicine" /></h1><div class="cAY"><span class="cAB">Capsules</span>, blue/pink, enclosing coated
beads, <span>itraconazole</span> 100 mg, net price 4-cap pack
= £3.67; 15-cap pack = £13.77; 28-cap pack (<span class="cZ">Sporanox</span>®<i>-Pulse</i>) = £25.72; 60-cap pack = £55.10. 
    Label:
    5, 9, 21, 25, counselling, hepatotoxicity</div><div class="cAY"><span class="cAB">Oral liquid</span>, sugar-free, cherry-flavoured, <span>itraconazole</span> 10 mg/mL, net price 150 mL (with 10-mL measuring
cup) = £58.34. 
    Label:
    9, 23, counselling, administration, hepatotoxicity<div class="cAQ"><div class="cAF"><h2>Dose</h2> <p class="cAF">oral or oesophageal candidiasis in HIV-positive or other
immunocompromised patients, 20 mL (2 measuring cups) daily in 1–2
divided doses for 1 week (continue for another week if no response)</p></div><div class="cAF"><p class="cAF"><span>Fluconazole</span>-resistant oral or oesophageal
candidiasis, 10–20 mL (1–2 measuring cups) twice daily for 2 weeks
(continue for another 2 weeks if no response; the higher dose should
not be used for longer than 2 weeks if no signs of improvement)</p></div><div class="cAF"><p class="cAF">Prophylaxis of deep fungal infections (when standard therapy
is inappropriate) in patients with haematological malignancy or undergoing
bone-marrow transplantation who are expected to become neutropenic,
5 mg/kg daily in 2 divided doses; starting before transplantation
or before chemotherapy (taking care to avoid interaction with cytotoxic
drugs) and continued until neutrophil count recovers; <span class="cAK">child</span> and <span class="cAK">elderly</span> safety
and efficacy not established</p></div><div class="cAV"><h3>Counselling</h3> <p class="cAX">Do not take with food; swish around
mouth and swallow, do not rinse afterwards</p></div></div></div><div class="cAY"><span class="cAB">Concentrate for intravenous infusion</span>, itraconazole 10 mg/mL. For dilution before use. Net price 25-mL
amp (with infusion bag and filter) = £79.71<div class="cAQ"><div class="cAO"><span class="cAG">Excipients </span> include propylene glycol</div></div></div></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="3974.htm">Previous: FLUCONAZOLE</a> | <a class="top" href="3982.htm#">Top</a> | <a accesskey="]" href="129707.htm">Next: POSACONAZOLE</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Privacy Policy">Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="35091.htm" rel="copyright">Copyright © BMJ Group and the Royal Pharmaceutical Society of Great Britain 2012. All rights reserved.</a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>